Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

Clicks: 417
ID: 111620
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs.
Reference Key
tv1999jamaanthrax Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Inglesby TV;Henderson DA;Bartlett JG;Ascher MS;Eitzen E;Friedlander AM;Hauer J;McDade J;Osterholm MT;O'Toole T;Parker G;Perl TM;Russell PK;Tonat K;;
Journal JAMA
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10328075
Keywords
vaccination National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine pregnancy research support non-u.s. gov't u.s. gov't adult female male adolescent Child Infant P.H.S. preschool United States Bacterial Vaccines immunocompromised host public health* vaccines practice guideline guideline anthrax* / drug therapy anthrax* / prevention & control pmid:10328075 doi:10.1001/jama.281.18.1735 consensus development conference t v inglesby d a henderson k tonat anthrax* / diagnosis bacillus anthracis / immunology biological warfare* decontamination environmental exposure infection control inactivated

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.